CADEFRECITINIB
UNII NKX4HH6CWK

Substance Identification & Data

This profile provides standardized clinical and technical data for Cadefrecitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NKX4HH6CWK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2308520-97-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

NKX4HH6CWK

CAS Registry Number

2308520-97-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CADEFRECITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H21N9O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GXELZXDURVDKHP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224721

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

138560421

Unique identification number in the NCBI database of chemical substances.

INN ID

13335

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CN(CCO1)c2nnc(cc2)Nc3c4ncn(C)c4nc(Oc5cnc(cc5C)C#N)c3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cadefrecitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.